Inhibition of H3K4 demethylation induces autophagy in cancer cell lines.
Biochim Biophys Acta. 2017 Aug 08;:
Authors: Wang Z, Long QY, Chen L, Fan JD, Wang ZN, Li LY, Wu M
Epigenetic factors and related small molecules have emerged to be strongly involved in autophagy process. Here we report that 2-PCPA and GSK-LSD1, two inhibitors of histone H3K4 demethylase KDM1A/LSD1, induce autophagy in multiple mammalian cell lines. The two small molecules induce accumulation of LC3II, formation of autophagosome and autolysosome, and SQSTM1/p62 degradation. 2-PCPA treatment inhibits cell proliferation through cell cycle arrest but does not inducing cell death. Exogenous expression of KDM1A/LSD1 impaired the autophagic phenotypes triggered by 2-PCPA. The autophagy induced by 2-PCPA requires LC3-II processing machinery. But depletion of BECN1 and ULK1 with siRNA did not affect the LC3-II accumulation triggered by 2-PCPA. 2-PCPA treatment induces the change of global gene expression program, including a series of autophagy-related genes, such as SQSTM1/p62. Taken together, our data indicate that KDM1A/LSD1 inhibitors induces autophagy through affecting the expression of autophagy-related genes and in a BECN1-independent manner.
PMID: 28800922 [PubMed – as supplied by publisher]
from #PM All via ola Kala on Inoreader http://ift.tt/2wFOnE8